Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03821324 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring
A NA study, sponsored by Venus Concept.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03821324 is a NA study that has completed, run by Venus Concept. The registered enrollment target is 15 participants.
The verdict
NCT03821324, a NA study, has completed, sponsored by Venus Concept.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate the progress of 15 subjects requesting treatment of acne scarring. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.
Interventions
- DEVICE Venus Viva
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-12-11 |
| Est. Completion | 2019-10-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03821324
The ClinicalTrials.gov registry entry for NCT03821324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Venus Viva is the first listed.
NCT03821324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03821324 about?
NCT03821324 is a clinical study titled "Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring". Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate the progress of 15 subjects requesting treatment of acne scarring. The study will involve three treatments on bo...
What is the current status of trial NCT03821324?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-12-11. Estimated completion is 2019-10-03.
What interventions are being tested in trial NCT03821324?
The interventions under investigation include: Venus Viva (DEVICE).
Who is sponsoring clinical trial NCT03821324?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.